VTYX
NASDAQ
US
Ventyx Biosciences, Inc. - Common Stock
$14.00
▲ +$0.02
(+0.14%)
Vol 851K
3
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$644.4M
ROE
-48.1%
D/E
0.00
Beta
1.26
52W
$1–$11
Wall Street Consensus
15 analysts · Apr 20262
Strong Buy
4
Buy
9
Hold
0
Sell
0
Strong Sell
40.0%
Buy Rating
Price Chart
Similar Stocks
HROW
Harrow Inc
$1.8B
SEPN
Septerna Inc
$1.2B
EYPT
EyePoint Inc
$1.5B
COLL
Collegium Pharmaceutical Inc
P/E 25.0
$1.5B
XERS
Xeris Biopharma Holdings Inc
$1.3B
AMPH
Amphastar Pharmaceuticals Inc
P/E 11.0
$1.2B
PCRX
Pacira Biosciences Inc
P/E 51.9
$1.1B
PHAT
Phathom Pharmaceuticals Inc
$1.2B
BIOA
BIOAGE Labs Inc
$474.4M
Earnings
Beat rate: 100.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Sep 2025 | $-0.46 | $-0.32 | +$0.14 |
| Jun 2025 | $-0.48 | $-0.38 | +$0.10 |
| Mar 2025 | $-0.49 | $-0.39 | +$0.10 |
| Dec 2024 | $-0.55 | $-0.41 | +$0.14 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -48.9% | -48.9% | -48.9% | -48.9% | -48.1% | -48.1% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 19.12 | 19.12 | 19.12 | 19.12 | 17.86 | 17.86 |
Key Ratios
ROA (TTM)
-43.9%
P/B
0.6
EPS (TTM)
$-1.50
CF/Share
$-3.13
52W High
$10.55
52W Low
$0.78
$0.78
52-Week Range
$10.55
How does VTYX compare to Pharmaceuticals peers?
Peer group: Micro-cap Pharmaceuticals (All) · 171 companies
VTYX valuation vs Pharmaceuticals peers
P/E ratio
—
▼
0%
below
peers
(22.4)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼
0%
below
peers
(5.0)
vs Peers
vs Industry
Overvalued
P/B ratio
0.6
▼
71%
below
peers
(2.1)
vs Peers
vs Industry
Undervalued
Div yield
—
▼
0%
below
peers
(2.0%)
vs Peers
vs Industry
Low yield
VTYX profitability vs Pharmaceuticals peers
ROE
-48.1%
▲
11%
above
peers
(-54.3%)
vs Peers
vs Industry
In line
Net margin
—
▼
0%
below
peers
(-47.4%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼
0%
below
peers
(68.3%)
vs Peers
vs Industry
In line
ROA
-43.9%
▼
17%
below
peers
(-37.4%)
vs Peers
vs Industry
Below avg
VTYX financial health vs Pharmaceuticals peers
D/E ratio
0.0
▼
100%
below
peers
(1.5)
vs Peers
vs Industry
Low debt
Current ratio
17.9
▲
432%
above
peers
(3.4)
vs Peers
vs Industry
Strong liquidity
Beta
1.3
▲
34%
above
peers
(0.9)
vs Peers
vs Industry
More volatile
VTYX fundamentals radar
VTYX
Peer median
Industry
VTYX profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
VTYX vs peers: key metrics
Latest News
No related news yet